SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Thomas Müller, Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease, Drugs, 2015, 75, 2, 157

    CrossRef

  2. 2
    Hayato Tabu, Toshihiko Aso, Masao Matsuhashi, Yoshino Ueki, Ryosuke Takahashi, Hidenao Fukuyama, Hiroshi Shibasaki, Tatsuya Mima, Parkinson's disease patients showed delayed awareness of motor intention, Neuroscience Research, 2015, 95, 74

    CrossRef

  3. 3
    Carla M. Lema Tomé, Trevor Tyson, Nolwen L. Rey, Stefan Grathwohl, Markus Britschgi, Patrik Brundin, Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?, Molecular Neurobiology, 2013, 47, 2, 561

    CrossRef

  4. 4
    O. Cooper, H. Seo, S. Andrabi, C. Guardia-Laguarta, J. Graziotto, M. Sundberg, J. R. McLean, L. Carrillo-Reid, Z. Xie, T. Osborn, G. Hargus, M. Deleidi, T. Lawson, H. Bogetofte, E. Perez-Torres, L. Clark, C. Moskowitz, J. Mazzulli, L. Chen, L. Volpicelli-Daley, N. Romero, H. Jiang, R. J. Uitti, Z. Huang, G. Opala, L. A. Scarffe, V. L. Dawson, C. Klein, J. Feng, O. A. Ross, J. Q. Trojanowski, V. M.- Y. Lee, K. Marder, D. J. Surmeier, Z. K. Wszolek, S. Przedborski, D. Krainc, T. M. Dawson, O. Isacson, Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease, Science Translational Medicine, 2012, 4, 141, 141ra90

    CrossRef

  5. 5
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  6. 6
    Anthony C. Vernon, Clive Ballard, Michel Modo, Neuroimaging for Lewy body disease: Is the in vivo molecular imaging of α-synuclein neuropathology required and feasible?, Brain Research Reviews, 2010, 65, 1, 28

    CrossRef

  7. 7
    Thomas Müller, New small molecules for the treatment of Parkinson's disease, Expert Opinion on Investigational Drugs, 2010, 19, 9, 1077

    CrossRef